TP53 and lung cancer: A combination of 6 AABs (p53, NY-ESO-1, CAGE, GBU4-5, Annexin1, and SOX2), known as Early CDT-Lung, showed high specificity (89%) and sensitivity of 43% for early-stage lung cancer (12).